Takeda Pharmaceutical Income Statement (2018-2026) | TAK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2018	Mar2019	Mar2020	Mar2021	Mar2022	Mar2023	Mar2024	Mar2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)									7.11B
Cost of Revenue (Quarter)									2.64B
Gross Profit (Quarter)									4.47B
Operating items
Selling, General & Administrative (Quarter)									-1.92B
Operating Expenses (Quarter)									-1.92B
Operating Income (Quarter)									1.31B
EBIT (Quarter)									1.31B
Non-operating items
Interest & Investment Income (Quarter)									0.10B
Net income details
EBT (Quarter)									1.08B
Tax Provisions (Quarter)									-0.29B
Profit After Tax (Quarter)									0.91B
Equity Income (Quarter)									-0.00B
Income from Non-Controlling Interests (Quarter)								0.01B	-0.00B	0.01B
Income from Continuing Operations (Quarter)									1.37B
Consolidated Net Income (Quarter)									1.37B
Income towards Parent Company (Quarter)									0.91B
Net Income towards Common Stockholders (Quarter)									0.91B
Additional items
Shares Outstanding (Weighted Average) (Quarter)	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	11.31B	448.07		0.00B
Shares Outstanding (Diluted Average) (Quarter)								440.67		762.89
EBITDA (Quarter)									1.31B
Interest Expenses (Quarter)									-0.32B
Tax Rate (Quarter)									-26.88%